Metabolic Regulation of the Immune Humoral Response

Slides:



Advertisements
Similar presentations
Cristoforo Grasso, Gerrit Jansen, Elisa Giovannetti 
Advertisements

MYC, Metabolism and Cancer
Rigel J. Kishton, Madhusudhanan Sukumar, Nicholas P. Restifo 
Lipid-Induced Mitochondrial Stress and Insulin Action in Muscle
Inositol as putative integrative treatment for PCOS
Cellular Metabolism and Disease: What Do Metabolic Outliers Teach Us?
Figure 1 mTOR pathway activation
Figure 1 Metabolic adaptations of cancer cells
Nat. Rev. Nephrol. doi: /nrneph
A Flt3L Encounter: mTOR Signaling in Dendritic Cells
Germinal Centers: Gaining Strength from the Dark Side
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Maria M. Mihaylova, David M. Sabatini, Ömer H. Yilmaz  Cell Stem Cell 
You Down With ETC? Yeah, You Know D!
Kaitlin A. Read, Michael D. Powell, Paul W. McDonald, Kenneth J
Is REDD1 a Metabolic Éminence Grise?
Metabolic Reprogramming of Immune Cells in Cancer Progression
Coming up for air: HIF-1 and mitochondrial oxygen consumption
Phosphoinositide Function in Cytokinesis
Patrick S. Ward, Craig B. Thompson  Cancer Cell 
A, diagram depicting receptor signaling and nutrient import.
PTEN Enters the Nuclear Age
Ketone bodies as signaling metabolites
Understanding the Intersections between Metabolism and Cancer Biology
Complementing T Cells’ Functions: Bringing in Metabolism Matters
Ng Shyh-Chang, George Q. Daley  Cell Metabolism 
The PI3K Pathway in Human Disease
An Emerging Role of mTOR in Lipid Biosynthesis
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Tumor Cell Metabolism: Cancer's Achilles' Heel
Russell G. Jones, Edward J. Pearce  Immunity 
Cancer Metabolism: Is Glutamine Sweeter than Glucose?
Mitochondria in the Regulation of Innate and Adaptive Immunity
Silencing Insulin Resistance through SIRT1
Hypoxia-Inducible Factors in Physiology and Medicine
Long Noncoding RNA in Hematopoiesis and Immunity
AKT/PKB Signaling: Navigating the Network
Conserved Metabolic Regulatory Functions of Sirtuins
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
Gabriela Andrejeva, Jeffrey C. Rathmell  Cell Metabolism 
Pierre Theurey, Jennifer Rieusset  Trends in Endocrinology & Metabolism 
AKT/PKB Signaling: Navigating Downstream
Wissam Assaily, Samuel Benchimol  Cancer Cell 
Pyruvate as a Pivot Point for Oncogene-Induced Senescence
Caroline A. Lewis, Matthew G. Vander Heiden  Immunity 
Biochemical Underpinnings of Immune Cell Metabolic Phenotypes
The TORC that Gets the GC Cycling
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
Volume 7, Issue 1, Pages (January 2008)
Jonathan D. Powell, Greg M. Delgoffe  Immunity 
Antigen-Receptor Signaling to Nuclear Factor κB
Volume 11, Issue 5, Pages (November 2012)
Modes of p53 Regulation Cell
mTOR and Akt Signaling in Cancer: SGK Cycles In
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Volume 159, Issue 6, Pages (December 2014)
Cytokine Signaling Modules in Inflammatory Responses
MYC-regulated metabolic pathways in cancer.
Sestrins Orchestrate Cellular Metabolism to Attenuate Aging
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Anthony T. Phan, Ananda W. Goldrath, Christopher K. Glass  Immunity 
Volume 35, Issue 6, Pages (December 2011)
Kathryn E. Wellen, Craig B. Thompson  Molecular Cell 
Sites and Stages of Autoreactive B Cell Activation and Regulation
Dysregulation of the mTOR Pathway Secondary to Mutations or a Hostile Microenvironment Contributes to Cancer and Poor Wound Healing  Richard A.F. Clark,
Novel aspects of complement in kidney injury
Raffaele Teperino, Kristina Schoonjans, Johan Auwerx  Cell Metabolism 
Nutrient Sensing, Metabolism, and Cell Growth Control
Main metabolic pathways deregulated in cancers and corresponding targeting drugs. Main metabolic pathways deregulated in cancers and corresponding targeting.
Volume 7, Issue 1, Pages (January 2008)
Presentation transcript:

Metabolic Regulation of the Immune Humoral Response Mark Boothby, Robert C. Rickert  Immunity  Volume 46, Issue 5, Pages 743-755 (May 2017) DOI: 10.1016/j.immuni.2017.04.009 Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 1 The Carbon Economy: Fuel and Build A schematic of the concepts and salient details outlined in the text. (A) Both during quiescence and after activation and during growth, B cells need to balance the utilization of nutrients so as to generate ATP while also using portions of the uptake supply to provide building blocks for new molecule synthesis. As discussed in the text, the energy and atoms also get used for regulatory modifications such as histone post-translational modification by acetylation or methylation, or as cofactors of dioxygenases involved in HIF stabilization or the editing of chromatin methylation. Anabolic processes require both energy (ATP and GTP used in glycosylation as well as protein, lipid, and nucleic acid synthesis) and the importation of sufficient building blocks. (B) Three major categories of fuel source are shown, along with some (but not all) of the branch points in their utilization. The plasma membrane is symbolized by an intermittent dotted line, in which nutrient importers are shown in simplified form (for instance, many can operate bi-directionally; some operate with export coupled to the import process shown). The mitochondrion is shown as a blue-bordered box, with only the Krebs cycle shown from among its many functions. Abbreviations: MCT, monocarboxylate transporter; LDH, lactate dehydrogenase; G6P, glucose-6-phosphate; ACLY, ATP-citrate lyase; PDH, pyruvate dehydrogenase; Ac-CoA, acetyl-Coenzyme A; αKG, alpha-ketoglutarate, also known as 2-oxoglutarate; TCA, tricarboxylic acid; GLS, glutaminase; ASCT2, Alanine, serine, cysteine-preferring transporter 2 (SLC1A5); LAT1, L-type amino acid transporter 1 (SLC7A5); NEAA, non-essential amino acids. Immunity 2017 46, 743-755DOI: (10.1016/j.immuni.2017.04.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 2 Overview of Receptors and Signal Transducers Linked to Metabolic Regulation (A) A simplified view of cell surface receptors mediating B cell homeostasis and activation. For convenience, the PI 3-kinase activation is highlighted, as naive and activated B cells are combined, along with helper T cells. Collaboration of BAFF-R, BCR, and CD19, as noted in the text, is schematized. (B) A simplified diagram of signaling pathways linking surface receptors and metabolism in B cells. At the top level, multiple inputs into the phosphoinositide 3-kinase (PI3K) pathway from antigen (Ag) receptor, costimulators, and cytokine receptors are shown, along with PTEN conversion of phosphatidylinositol 4, 5-biphosphate (PIP2) to phosphatidylinositol 3, 4, 5-triphosphate (PIP3). The dual lipid-protein phosphatase PTEN (Phosphatase and tensin homolog) restrains the pathway. Antigen receptor signaling also includes activation of protein kinases C (PKC). Abbreviations are as follows: PDK1, phospho-inositide-dependent kinase 1; TSC, tuberous sclerosis complex; GSK, glycogen synthase kinase; WNT, Wingless-related integration site; AMPK, AMP-activated kinase. Immunity 2017 46, 743-755DOI: (10.1016/j.immuni.2017.04.009) Copyright © 2017 Elsevier Inc. Terms and Conditions

Figure 3 Transcriptional Regulation of B Cell Metabolism Schematic shows initial B cell activation by antigen and T cell help leading to the upregulation (green text) and downregulation (red text) of key transcription factors. Events in the germinal center are dynamic as B cells traverse between selection in the hypoxic light zone (LZ) and proliferation in the dark zone (DZ). In the LZ, B cells retrieve antigen from follicular dendritic cell-bound antigen for presentation to Tfh cells that reciprocate by providing cytokine support in the form of CD40L, IL-4, and IL-21. These cytokines induce the expression of select transcription factors that drive aspects of the metabolic program. The transcription factors c-Myc, HIF, and STAT6 promote expression of glycolytic genes, whereas Bcl6 suppressed the transcription of some of the same target genes. HIF inhibits c-Myc activity which, among other events, would impair transcription of AP4 target genes. Immunity 2017 46, 743-755DOI: (10.1016/j.immuni.2017.04.009) Copyright © 2017 Elsevier Inc. Terms and Conditions